133 related articles for article (PubMed ID: 14595790)
1. Effectiveness of the SurePath liquid-based Pap test in automated screening and in detection of HSIL.
Cengel KA; Day SJ; Davis-Devine S; Adams CL; Madison-Henness D; Hartman ME; Freund GG
Diagn Cytopathol; 2003 Nov; 29(5):250-5. PubMed ID: 14595790
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
3. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests.
Kahn SL; Ronnett BM; Gravitt PE; Gustafson KS
Cancer; 2008 Feb; 114(1):57-64. PubMed ID: 18181097
[TBL] [Abstract][Full Text] [Related]
4. Relative risk of high grade squamous intraepithelial lesion associated with prior abnormal Pap smears.
Collins LC; Niloff J; Burke L; Abu-Jawdeh G; Wang H
J Reprod Med; 2001 Feb; 46(2):105-9. PubMed ID: 11255808
[TBL] [Abstract][Full Text] [Related]
5. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
[TBL] [Abstract][Full Text] [Related]
6. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
7. The PapSpin: a reasonable alternative to other, more expensive liquid-based Papanicolaou tests.
Rosenthal DL; Geddes S; Trimble CL; Carson KA; Alli PM
Cancer; 2006 Jun; 108(3):137-43. PubMed ID: 16628656
[TBL] [Abstract][Full Text] [Related]
8. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
Wilgenbusch H; Mueller G; Neal M; Renshaw AA
Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
10. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
Nasser SM; Cibas ES; Crum CP; Faquin WC
Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
[TBL] [Abstract][Full Text] [Related]
11. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity.
Sass MA
Acta Cytol; 2004; 48(1):17-22. PubMed ID: 14969176
[TBL] [Abstract][Full Text] [Related]
12. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.
Cox JT
J Natl Compr Canc Netw; 2004 Nov; 2(6):597-611. PubMed ID: 19780303
[TBL] [Abstract][Full Text] [Related]
13. Results of an Australian trial using SurePath liquid-based cervical cytology with FocalPoint computer-assisted screening technology.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2012 Dec; 40(12):1093-9. PubMed ID: 22045553
[TBL] [Abstract][Full Text] [Related]
14. Cervical parakeratosis/hyperkeratosis as an important cause for false negative results of Pap smear and human papillomavirus test.
Xiao GQ; Emanuel PO
Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):302-6. PubMed ID: 19566565
[TBL] [Abstract][Full Text] [Related]
15. Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2015 Nov; 43(11):870-8. PubMed ID: 26174002
[TBL] [Abstract][Full Text] [Related]
16. Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark.
Rebolj M; Rask J; van Ballegooijen M; Kirschner B; Rozemeijer K; Bonde J; Rygaard C; Lynge E
Br J Cancer; 2015 Nov; 113(9):1259-74. PubMed ID: 26448176
[TBL] [Abstract][Full Text] [Related]
17. Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure.
Sturgis CD; Schaaf MR; Tickman RJ
Diagn Cytopathol; 2013 May; 41(5):399-403. PubMed ID: 22351303
[TBL] [Abstract][Full Text] [Related]
18. Role of Pap Test terminology and age in the detection of carcinoma invasive and carcinoma in situ in medically underserved California women.
Howell LP; Tabnak F; Tudury AJ; Stoodt G
Diagn Cytopathol; 2004 Apr; 30(4):227-34. PubMed ID: 15048955
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears.
Guo M; Hu L; Martin L; Liu S; Baliga M; Hughson MD
Acta Cytol; 2005; 49(2):132-8. PubMed ID: 15839615
[TBL] [Abstract][Full Text] [Related]
20. Correlation of conventional and liquid-based cytology and their meaning in management of precancerous cervical lesions.
Milanova E; Naumov J; Nikolovska E; Damcevski N
Akush Ginekol (Sofiia); 2005; 44(1):60-2. PubMed ID: 15853017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
